Assessing health system preparedness for MASLD in the Middle East and North Africa
Background and aims Metabolic dysfunction-associated steatotic liver disease (MASLD) represents an escalating healthcare burden across the Middle East and North...
MASLD
The importance of patient engagement in the multimodal treatment of MASLD
World Health Organization. Noncommunicable Diseases (NCD) (WHO, 2019). www.who.int/gho/ncd/mortality_morbidity/en/.Riazi, K. et al. The prevalence and incidence of NAFLD worldwide: a...
American Liver Foundation aiming to improve MASLD patient care
The American Liver Foundation (ALF) has launched two projects that aim to improve care for people with metabolic dysfunction-associated steatotic...
